This company listing is no longer active
VHT Stock Overview
Provides breast imaging analytics software products in New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Volpara Health Technologies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.15 |
| 52 Week High | AU$1.15 |
| 52 Week Low | AU$0.63 |
| Beta | 1.67 |
| 1 Month Change | 0.44% |
| 3 Month Change | 2.23% |
| 1 Year Change | 59.03% |
| 3 Year Change | -7.66% |
| 5 Year Change | -35.49% |
| Change since IPO | 129.00% |
Recent News & Updates
Recent updates
What Volpara Health Technologies Limited's (ASX:VHT) 52% Share Price Gain Is Not Telling You
Dec 19
We're Hopeful That Volpara Health Technologies (ASX:VHT) Will Use Its Cash Wisely
Mar 06Calculating The Intrinsic Value Of Volpara Health Technologies Limited (ASX:VHT)
Jun 03Does Volpara Health Technologies (ASX:VHT) Have A Healthy Balance Sheet?
Mar 24Volpara Health Technologies (ASX:VHT) Shareholders Booked A 93% Gain In The Last Three Years
Jan 28Volpara Health Technologies (ASX:VHT) Is Using Debt Safely
Dec 24Here's What We Think About Volpara Health Technologies' (ASX:VHT) CEO Pay
Nov 19
Shareholder Returns
| VHT | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | 7.2% | 1.1% |
| 1Y | 59.0% | 94.5% | 3.4% |
Return vs Industry: VHT underperformed the Australian Healthcare Services industry which returned 83.4% over the past year.
Return vs Market: VHT exceeded the Australian Market which returned 9.6% over the past year.
Price Volatility
| VHT volatility | |
|---|---|
| VHT Average Weekly Movement | 0.7% |
| Healthcare Services Industry Average Movement | 12.6% |
| Market Average Movement | 9.3% |
| 10% most volatile stocks in AU Market | 16.7% |
| 10% least volatile stocks in AU Market | 4.1% |
Stable Share Price: VHT has not had significant price volatility in the past 3 months.
Volatility Over Time: VHT's weekly volatility has decreased from 9% to 1% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 156 | Teri Thomas | www.volparahealth.com |
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients’ risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters.
Volpara Health Technologies Limited Fundamentals Summary
| VHT fundamental statistics | |
|---|---|
| Market cap | AU$291.26m |
| Earnings (TTM) | -AU$8.16m |
| Revenue (TTM) | AU$34.72m |
8.4x
P/S Ratio-35.7x
P/E RatioIs VHT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VHT income statement (TTM) | |
|---|---|
| Revenue | NZ$37.96m |
| Cost of Revenue | NZ$2.93m |
| Gross Profit | NZ$35.03m |
| Other Expenses | NZ$43.95m |
| Earnings | -NZ$8.92m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.035 |
| Gross Margin | 92.27% |
| Net Profit Margin | -23.50% |
| Debt/Equity Ratio | 0% |
How did VHT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/21 17:08 |
| End of Day Share Price | 2024/05/16 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Volpara Health Technologies Limited is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| John Hester | Bell Potter |
| Russell Wright | Maqro Capital |